50 studies found for:    Open Studies | "Hypoglycemic Agents"
Show Display Options
Rank Status Study
21 Recruiting Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Mellitus Patients Not Achieving Glycemic Targets on Basal Insulin With/Without Anti-Hyperglycemic Agents
Condition: Diabetes Mellitus, Type 2 (T2DM)
Interventions: Device: Bolus Insulin Patch (Calibra Finesse);   Device: Insulin Pen (Novo-Nordisk FlexPen®)
22 Not yet recruiting Efficacy and Safety of LixiLan Versus Insulin Glargine Alone Both With Metformin in Japanese With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Drugs
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Insulin glargine/Lixisenatide (HOE901/AVE0010);   Drug: Insulin glargine U100 (HOE901);   Drug: Metformin
23 Unknown  Genetic Variation in the Transporters and Hypoglycemic Agents
Condition: Type 2 Diabetes
Intervention:
24 Unknown  Observational Registry for Basal Insulin Treatment Study (ORBIT)
Condition: Diabetes
Intervention:
25 Unknown  Diazoxide In the Management Of Hypoglycemic Neonates
Conditions: Infant, Newborn, Diseases;   Pregnancy in Diabetics;   Infant, Diabetic Mother;   Hypoglycemia;   Infant, Large for Gestational Age
Interventions: Drug: Diazoxide;   Drug: Ora-plus
26 Recruiting The Practical Evidence of Antidiabetic Combination Therapy in Korea
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: alogliptin;   Drug: Pioglitazone;   Drug: alogliptin + pioglitazone
27 Unknown  The Effects of Hypolipemic and Antidiabetic Treatment on Cytokines
Conditions: Diabetes;   Dyslipidemia;   Inflammation;   Cytokines
Intervention: Drug: Metformin 1000mg, simvastatin 10mg and fenofibrate 100mg
28 Recruiting Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Lixisenatide on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Insulin glargine/Lixisenatide (HOE901/AVE0010);   Drug: Lixisenatide (AVE0010);   Drug: Oral anti-diabetic drugs
29 Not yet recruiting Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Insulin Glargine Alone on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Insulin glargine/lixisenatide (HOE901/AVE0010);   Drug: Insulin glargine (HOE901);   Drug: Oral anti-diabetic drugs
30 Not yet recruiting Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor Agonist
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: INSULIN GLARGINE (U300);   Drug: Insulin degludec;   Drug: GLP-1 receptor agonist;   Drug: Glimepiride;   Drug: Metformin
31 Recruiting Treatment of Type 2 Diabetes With Long Acting Basal Insulin in Jordan
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: INSULIN GLARGINE
32 Unknown  Shiga Progression of Diabetes, Nephropathy and Retinopathy
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Pioglitazone add on to SU or biguanide;   Drug: SU or Biguanide
33 Recruiting Comparison of Two Titration Programs of Adding Insulin Detemir to OADs in Poorly Controlled Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Behavioral: Active titration algorithm;   Behavioral: Usual titration algorithm
34 Unknown  Influence of DPP-4 on Inflammatory Parameters in Diabetics: Gender Aspects
Conditions: Type 2 Diabetes Mellitus;   Cardiovascular Risk;   Endothelial Dysfunction
Intervention:
35 Recruiting Acute Liver Injury in Patients on Dapagliflozin
Condition: Acute Liver Injury
Intervention:
36 Not yet recruiting A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: Dulaglutide;   Drug: Placebo
37 Recruiting Complications of UTI in Patients on Dapagliflozin
Condition: Severe Complications of Urinary Tract Infections
Intervention:
38 Recruiting COMPLEMENT Study- A First in Human Study of Metabolic Neuromodulation Therapy
Conditions: Diabetes;   Endocrine, Nutritional and Metabolic Diseases (E00-E89)
Intervention: Device: Metabolic Neuromodulation System (MNS)
39 Recruiting The Role of Endogenous Lactate in Brain Preservation and Counterregulatory Defenses Against Hypoglycemia
Conditions: Type 1 Diabetes Mellitus;   Hypoglycemia Unawareness
Interventions: Behavioral: High intensity exercise;   Behavioral: Lay down comfortably
40 Unknown  Gastric Modulator (TANTALUS® System) Versus Insulin Treatment in Obese Type 2 Diabetic Patients - a Randomized Control Trial
Condition: Type 2 Diabetes Mellitus
Interventions: Device: Tantalus;   Drug: Insulin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-50) Show next page of results    Last Page
Indicates status has not been verified in more than two years